Related Experiment Videos
[Cardiovascular manifestations of systemic elastorrhexis]
1Division des soins intensifs chirurgicaux, département APSIC, hôpital cantonal universitaire de Genève, 1211 Genève 14, Suisse. Karim.Bendjelid@hcuge.ch
Summary
Systemic elastorrhexis, a rare inherited disorder, affects elastic tissues and can cause early-onset coronary artery disease. Early detection is crucial, especially without typical risk factors, aiding diagnosis and management.
Area of Science:
- Genetics and rare diseases
- Cardiovascular pathology
- Connective tissue disorders
Context:
- Systemic elastorrhexis (Grönblad-Strandberg-Touraine syndrome) is a rare inherited disorder causing generalized elastic tissue dysplasia.
- Key affected tissues include skin, eyes, and arteries, leading to diverse clinical manifestations.
- Cardiovascular complications are common, including early-onset coronary artery disease in about 20% of patients.
Purpose:
- To review the literature on systemic elastorrhexis and its cardiovascular implications.
- To highlight the association between this rare condition and early-onset severe coronary artery disease.
- To emphasize the importance of considering elastorrhexis in patients with arteriopathy and no vascular risk factors.
Summary:
- Systemic elastorrhexis is an inherited condition with significant cardiovascular manifestations, notably early-onset coronary artery disease.
- The review stresses the need to investigate elastorrhexis in cases of premature severe coronary or arterial disease, particularly when cardiovascular risk factors are absent.
- Genetic linkage to chromosome 16p13.1 suggests potential for future diagnostic advancements, possibly avoiding invasive biopsies.
Impact:
- Enhances understanding of rare inherited connective tissue disorders and their cardiovascular sequelae.
- Promotes earlier diagnosis of systemic elastorrhexis, enabling timely intervention for cardiovascular complications.
- Guides clinicians in suspecting elastorrhexis in atypical presentations of coronary artery disease, improving patient outcomes.